- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04350775
Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia
August 31, 2023 updated by: En-Chi Chiu, National Taipei University of Nursing and Health Sciences
This is a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of Reablement-Instrumental Activities of Daily Living (RE-IADL) on schizophrenia patients at immediately and long-term.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Subjects will be randomized to intervention group and control group.
The outcome measures include the Canadian Occupational Performance Measure, Instrumental Activities of Daily Living-3 Dimensions, Activities of Daily Living Rating Scale III, Frenchay Activities Index, Lawton Instrumental Activities of Daily Living, Mini Mental State Examination-2nd edition, Behavior Rating Inventory of Executive Function adult version, Allen Cognitive Level Screen-6th, Participation Measure-3 Domains, 4 Dimensions, Personal and Social Performance scale, Work Behavior Inventory, Schizophrenia-Quality of Life questionnaire, Beck Depression Inventory-II, and Functioning Scale of the Disability Evaluation System.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: En-Chi Chiu, PhD
- Phone Number: 6206 +886-2-28227101
- Email: enchichiu@ntunhs.edu.tw
Study Locations
-
-
Wanhua Dist
-
Taipei, Wanhua Dist, Taiwan, 108306
- National Taipei University of Nursing and Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of schizophrenia by DSM-5
- age > 20 years
- Stable mental symptoms
- Willing to sign the subject's consent
Exclusion Criteria:
- History of severe brain injury
- Substance abuse
- Diagnosis of intellectual developmental disorder
- Unable to follow instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RE-IADL group
Reablement
|
RE-IADL program is to conduct trainings related to instrumental activities of daily living.
For example,using communication appliance, moving in community, financial management, health care, housework, prepare meals and clear ,and shopping.
|
Placebo Comparator: Control group
General community rehabilitation
|
General community rehabilitation contains the activities in psychiatric rehabilitation center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes of the Canadian Occupational Performance Measure
Time Frame: 18 weeks
|
The Canadian Occupational Performance Measure assesses occupational performance.
A higher score indicates better occupational performance.
Changes of the Canadian Occupational Performance Measure will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Instrumental Activities of Daily Living-3 Dimensions
Time Frame: 18 weeks
|
The Instrumental Activities of Daily Living-3 Dimensions assesses instrumental activities of daily living about 3 Dimensions.
A higher score indicates better instrumental activities of daily living.
Changes of the Instrumental Activities of Daily Living-3 Dimensions will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Activities of Daily Living Rating Scale III
Time Frame: 18 weeks
|
The Activities of Daily Living Rating Scale III assesses activities of daily living.
A higher score indicates better activities of daily living.
Changes of the Activities of Daily Living Rating Scale III well be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Frenchay Activity Index
Time Frame: 18 weeks
|
The Frenchay Activity Index assesses instrumental activities of daily.
A higher score indicates better instrumental activities of daily living.
Changes of the Frenchay Activity Index will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Lawton Instrumental Activities of Daily Living
Time Frame: 18 weeks
|
The Lawton Instrumental Activities of Daily Living assesses instrumental activities of daily living.
A higher scores indicates better instrumental activities of daily living.
Changes of the Lawton Instrumental Activities of Daily Living will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Mini Mental State Examination-2nd edition
Time Frame: 18 weeks
|
The Mini Mental State Examination assesses general cognitive function.
A higher score indicates better general cognitive function.
Changes of the Mini Mental State Examination will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Behavior Rating Inventory of Executive Function adult version
Time Frame: 18 weeks
|
The Behavior Rating Inventory of Executive Function adult version assesses executive functions.
A lower score indicates better executive functions.
Changes of the Behavior Rating Inventory of Executive Function adult version will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Allen Cognitive Level Screen-6th
Time Frame: 18 weeks
|
The Allen Cognitive Level Screen-6th assesses cognitive functions.
A higher score indicates better cognitive functions.
Changes of the Allen Cognitive Level Screen-6th will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Participation Measure-3 Domains, 4 Dimensions
Time Frame: 18 weeks
|
The Participation Measure-3 Domains, 4 Dimensions assesses social participation.
A higher score indicates better social participation.
Changes of the Participation Measure-3 Domains, 4 Dimensions will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Personal and Social Performance scale
Time Frame: 18 weeks
|
The Personal and Social Performance scale assesses social functioning.
A higher score indicates better social functioning.
Changes of the Personal and Social Performance scale will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Work Behavior Inventory
Time Frame: 18 weeks
|
The Work Behavior Inventory assesses work behavior about chronic mental patients.
A lower score indicates better work behavior.
Changes of the Work Behavior Inventory will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Schizophrenia-Quality of Life questionnaire
Time Frame: 18 weeks
|
The Schizophrenia-Quality of Life questionnaire assesses schizophrenia quality of life.
A higher score indicates better quality of life.
Changes of the Schizophrenia-Quality of Life questionnaire will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Beck Depression Inventory-II
Time Frame: 18 weeks
|
The Beck Depression Inventory-II assesses the person about depression.
A higher score indicates more depression.
Changes of the Beck Depression Inventory-II will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Changes of the Functioning Scale of the Disability Evaluation System
Time Frame: 18 weeks
|
The Functioning Scale of the Disability Evaluation System assesses status of individuals' activities and participation.
A higher score indicates more barriers or limitations.
Changes of the Functioning Scale of the Disability Evaluation System will be assessed at the 0 week, 6 weeks, and 18 weeks.
|
18 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: En-Chi Chiu, PhD, National Taipei University of Nursing and Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2021
Primary Completion (Actual)
July 6, 2022
Study Completion (Actual)
July 6, 2022
Study Registration Dates
First Submitted
April 15, 2020
First Submitted That Met QC Criteria
April 15, 2020
First Posted (Actual)
April 17, 2020
Study Record Updates
Last Update Posted (Actual)
September 1, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TCHIRB-10812015
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Rakitzi, StavroulaActive, not recruiting
-
Peking UniversityNot yet recruitingTreatment-resistant Schizophrenia
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
Clinical Trials on RE-IADL
-
Hospices Civils de LyonCompleted
-
Zurich University of Applied SciencesCompletedMild Cognitive Impairment | Mild DementiaSwitzerland
-
Florida State UniversityCompletedCognitive AgingUnited States
-
Ege UniversityNot yet recruiting
-
Nantes University HospitalCompleted
-
University of BirminghamUniversità degli studi di Roma Foro Italico; Loughborough University; Metabolic...Terminated
-
University Hospital HeidelbergRecruitingLocally Advanced Head-and-Neck CancerGermany
-
Technical University of MunichCharite University, Berlin, Germany; Translationales intensivmedizinisches...CompletedCritical Illness | Assessment, Self | Self-AssessmentGermany
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedObstructive Sleep Apnea SyndromeFrance
-
University of Alabama at BirminghamNot yet recruitingRecurrent Malignant Glioma | Glioblastoma Multiforme of Brain | Anaplastic Astrocytoma of Brain | Gliosarcoma of BrainUnited States